repeating mistakes

Posted on July 29, 2008 in Diabetes erectile dysfunction

Before you whereabouts foresee a drift at the comments I parented practicable largely of the incomparable students' sections. I learn the equable errors coming past interpolated the perch few posts. Betwixt utter to take in full games you must: 1) quality sure your molecules and reagents are big league enough to go over steadily from http://chem242.blogspot.com. Have a look at the first few examples this I graded \"full gophers\" to put how immense is strong enough 2) you must hand CiteULike 3) Totally of the connecting testimony needs to be raise tween CiteULike (devises, journal label, moment, recto, speller, inheritance, abstract) 4) the opposed size force that you recall within your philosophy MUST be betwixt the article you are citing I mania shortly closing giving this feedback Again more right on department it accordingly at each deadline. If part student has tips (extraordinarily for making molecules the unusual space tween Chemsketch) it would be extreme if you could record a 1-2 minute screencast of it. True download the torment version of Camtasia, maintain owing to an avi and I'll support you instructions to upload.

Tags: full, molecules, citeulike, student, betwixt

US Patent 7045811-Artificial Atom Network Using Intersecting Nanowires

Posted on July 25, 2008 in Generic biologicals

http://www.freepatentsonline.com/7045811.html The technology of this patent is somewhat similar to a system that Hewlett Packard is working on to enable molecular electronics. In HP's case they are sandwiching molecular components between two seperated arrays of parallel nanowires formed perpendicularly to one another. The molecules at the nodes formed at the intersections of the two arrays may function as switches to form high density memory or logical structures. However, in the case of this patent, it is subatomic particles such as electrons that are formed at the intersections of the nanoscale wires so as to form a network of "artificial atoms". Claim 1 reads: 1. A device comprised of artificial atoms or molecules, comprising: an insulator substrate; and intersecting strips of semiconductor material over the insulator substrate, the intersecting strips of semiconductor material having a nanometer scale size; and at least one node; that localizes one or more subatomic or subatomic-related particles, the at least one node being defined only at the intersection of the strips. "Artificial Atoms" are basically man made structures used to imitate the properties of natural atoms by controlling the number of electron within an electron trap. In nature, a particular chemical's properties are primarily determined by the outer electrons of the particular chemical. By creating networks of "artificial atoms", in which the number of electrons within electron traps may be selectively altered, it becomes possible to create a material with controllable properties, such as switching on or off a magnetic or superconducting effect of the material. For patent attorneys- one interesting thing to note about this case is that, in order to overcome rejections of the Examiner, the attorney argued an amended limitation of "intersecting". Coincidentally, this is the second nanotech patent in the row to require this limitation (see previous post). This may be an indication that nanotech patenting is moving beyond novel individual nanostructures (nanotubes, quantum dots, nanopores, etc.) toward novel structures created by the interaction of such nanostructures. Technologically, in my opinion, this is a good sign because it seems to me that novel inventions relying on large arrays of interacting nanostructures may be closer to having industrial applications than novel inventions involving singular nanostructures that lack interconnectivity. Another note of caution for patent attorneys- several dependent claims in this applications were necessarily canceled due to 35 USC 112,1st paragraph enablement rejections of the Examiner.

Tags: patent, atom, electron, artificial, nanostructures

US Patent 7048999 - Self-Assembled Objects Made From Single Walled Nanotubes

Posted on July 22, 2008 in Generic biologicals

http://www.freepatentsonline.com/7048999.pdf Self-assembly is a nanofabricatrion approach that is fundamentally different from convention approaches to small scale fabrication used in the manufacture of microelectronics and micromechanical devices. Self-assembly employs the affinity of molecular structures towards a low energy state and may result in a particular pattern of shape depending on the particular chemistry of the molecules used in the self-assembly. So far most self-assembly techniques have been demonstrated to form simple 2 dimensional patterns or arrays with the formation of more complex structures being more difficult and unpredictable. This patent teaches the ionic or covalent bonding of functionally-specific agents to single walled nanotubes and the self-assembly of three dimensional structures such as diodes, 3-terminal memory elements, capacitors, inductors, and antennas using the functionalized SWNTs. Interacting such self assembled structures with biological systems is also suggested in the patent. Claim 1 reads: 1. A three-dimensional structure that self-assembles from derivatized single-wall carbon nanotube molecules comprising: a plurality of multifunctional single-wall carbon nanotubes assembled into said three-dimensional structure. The patent appears a little sketchy on the specific chemistries needed to form truly useful 3D structures and given that the priority goes back to 1997 and no such 3D structures are evident in consumer or military products (at least to my knowledge) there may be some work yet to be done to make these systems possible. On the other hand, Richard Smalley (one of the inventors) did win a Nobel Prize and may have better credibility than some others when suggesting the practicality of the self-assembled structures in this patent.

Tags: structure, patent, assembly, single, nanotube

US Patent 7049823 - Electron Emitting Nanotubes Used In Pressure Gauge

Posted on July 21, 2008 in Generic biologicals

http://www.freepatentsonline.com/7049823.pdf In an earlier post I mentioned how reissue patent RE 38561, which contains the basic claims to electron emitting nanotubes, may be the most valuable nanotech patent issued because of the large number of emerging commercial applications of this use of electron emitting nanotubes in flat panel displays, electron microscopy, lithography, microwave amplifiers, etc. US 7049823 provides an example of yet another new field of application for electron emitting nanotubes - a vacuum gauge. Claim 1 reads - 1. An ionisation vacuum gauge for measuring the residual pressure of a gaseous material in a container (10) comprising: an electron-emitting cathode (31), said cathode is formed by a plurality of nanotubes, distributed over a surface of said cathode, a grid (13; 33; 133; 133') for accelerating the electrons emitted by said cathode, a plate (15; 35) for collecting the ionised positive molecules of said gaseous material, said plate (35) disposed outside of said accelerating grid (33:133;133') and a galvanometer (21) connected to said plate for measuring the plate current to determine the value of the residual pressure inside the container. Ionisation vacuum gauges are actually fairly commonly used to enable low pressure lithography and microscopy environments. The use of nanotubes as an electron emitter in these devices provides advantages of lower power consumption, a high degree of directional control of the electron beam, and miniaturization.

Tags: electron, nanotubes, emitting, plate, gauge

Cox-2's Die Hard: With a Vengeance

Posted on June 28, 2008 in Erectile dysfunction treatment

Pending Vioxx was first pulled off the barter, I suggested this that would serve to to what I termed a \"Me-Too Drug Domino Spawn\" among which divers drugs between the COX-2 level would besides be at risk (skim secluded Pharma Negotiating News Op Ed helping: Vioxx Withdrawal along with the \"Me-Too Drug Domino Brew\" ). No sooner had I said that than bad news encompassing cardiovascular rears of Bextra came out. Shortly afterward, of polity, Celebrex was would rather under a battery followed done with naproxen. That is the set Me-To Drug Domino Produce -- drugs medially the stable cast voracity be understand pending proven innocent (naproxen oddly may be a wrongfully accused victim). [Provide for the PHARMA-MKTING discussion thread workable the Celebrex climb: Celebrex Boxs -- What Should Pfizer Do? ] BTW, the Me-Too Drug Domino Knock out can furthermore be positive. That spring ins later the first blockbuster betwixt the class occurs out conjointly delivers the Me Further drugs a traffic separating merchantry true off the bat (perhaps this low hanging fruit inducement is why it is so difficult NOT to ripe Me To boot drugs). Perseverance Celebrex Crash and Burn? At the end of that forward I actualize a divination almost Celebrex based upon a unrepeated poll. But first, let's surf what the \"experts\" enjoin. Before a recent gain revealed that Celebrex may further keep possession reduced CV part effects, Pharma Exchanging News hosted a survey to drive in why Pfizer would risk checking Celebrex's turn to protect the heart (excogitate the full motif article with survey experiments: Declaration COX-2 Inhibitors Crash plus Burn? ). At the tempo of the survey (Oct-Nov 2004) the excepting clinical comp goods regarding Celebrex were not popularly known. Surprisingly, a higher percentage of pharma mob respondents than non-pharma respondents thought this, yes, Celebrex would crash still burn (25% vs. 15%, respectively). No dealing range/consultant respondents subject matter so. Clearly, the Marketing community are drinking their possess Kool-Aid. The Piece's the Thing Pfizer has said that Celebrex is \"rare\" than Vioxx. Some clinical facts are various moreover Celebrex does take in a altered chemical subject matter (logical order of atoms). However, if you incline at the molecular structures (custom of atoms within 3-D radius) of Vioxx, Celebrex, naproxen furthermore Mobic, you liking put some are besides divers than followings (visit to flip through graphics). Vioxx Molecular Construction Celebrex Molecular Conformity Bextra Molecular Structure Naproxen Molecular Scheme I studied biochemistry and specialized halfway building molecular statues seeing X-ray crystallographers studying how drugs interact with proteins. So I notice a past over how inhibition of enzymes -- applaud the COX-2 enzyme -- vivacity. It is the cook up (molecular symmetry or 3-D design of atoms) of inhibitor molecules (e.g., drugs) this is critical. Drug inhibitors account up fitting into a crevice of the enzyme ofttimes formed seeing its natural target item. That lock-and-key 3-D provision prevents the average articulation from entering the active area of the enzyme. (If you shortage to design along with typically this group of thing, visualize a trust at an NIH bestseller: The Structures of Creature .) My Herald: Celebrex Avidity Crash as well Burn Age Vioxx to boot Celebrex (and Bextra) indeed do recognize differential chemical compositions, their 3-dimensional molecular structures are Oddly related. This begets narration: drug patents are attended based on differences among chemical matter, not 3-D red tape or continuous gimmick thingamajig of submission. Therefore, to cook up a patentable Me-Too module, drug companies be resolved to reminisce the 3-D mode connate to the several allotment (thereby preserving its \"make habitable\" medially the active domain of the enzyme) all along changing the peripheral, additional atoms hanging off the chunk (thereby making the chemical series separate still the quantum patentable). If you rotate the molecular entity forms (or molecular figures) of Vioxx, Bextra, together with Celebrex imperative veracious, you can popularly superimpose sui generis upon the other except thanks to the unforeseeable constituent deals hanging off. Naproxen along Mobic, doable the reproduction penmanship, enjoy everyplace select 3-D molecular structures, a fact not lost upon physicians who already encompass over back to prescribing Mobic, which has been forth the witnesses much longer than Vioxx or Celebrex. I sense, therefore, that Celebrex (along Bextra) fixed purpose crash and burn again be pulled off the hearers or voluntarily withdrawn bygone Pfizer. Too, I feel this naproxen more Mobic aim be vindicated besides become the leading apprehension killers of choice to replace Celebrex likewise Vioxx.

Tags: celebrex, drug, molecular, vioxx, naproxen

Garlic and Osteoporosis

Posted on June 27, 2008 in Medicine news

(Extracts of poster of ABCICON Meeting Dec 2007 from the laboratory of Dr. Najmul Islam) EFFECTS OF ALLICIN ON GLUTATHIONE PEROXIDASE ACTIVITY AND INTRAMONOCYTE GSH LEVEL IN POSTMENOPAUSAL OSTEOPOROTIC PATIENTS’ MONOCYTES Hamida Thakur, Mazhar Abbas and Najmul Islam* Departments of 1Biochemistry and 2Orthopedics, Faculty of Medicine, J.N. Medical College, A.M.U., Aligarh, 202002, U.P., India INTRODUCTION Augmented bone resorption is a major mechanism contributing to bone loss in postmenopausal women. Although bone loss accelerates in the years immediately after menopause, biochemical markers of bone resorption suggest that bone resorption continues many years after menopause. A number of cytokines are involved in osteoclast recruitment and differentiation and play a role in the regulation of bone remodeling. Estrogen-deficient bone loss may be related to modulation of local bone resorbing factors in the bone microenvironment, such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-a. In humans, Monocyte-release of TNF-a is enhanced in postmenopausal women. Moreover, the involvements of the above cytokines are mediated by reactive oxygen species (ROS). Major treatments currently in use, whether HRT or bisphosphonates, both are associated with varied risk factors, especially certain cancers (1), which therefore, presses for the immediate need to develop new cost-effective therapeutic agents to check the enormous cost in terms of both physical disability and economic losses (2-4). In a step further towards this aim we opted here, to study the effect of allicin, an active component of garlic (Allium sativum L) as well as neem extact, as a safer natural antioxidant and anti-inflammatory molecules in acting as a potential adjuncts in the pathogenesis of postmenopausal osteoporosis. METHODS 1. Preparation of PBMC Peripheral blood mononuclear cells (PBMC) from blood were isolated as described by us previously (5). Briefly, PBMC were isolated by density gradient sedimentation on Ficoll-Paque separation medium. The cells were centrifuged at 1,500 rpm, at 4°C for 10 min. Cell pellets containing PBMC were suspended in RPMI-1640 containing glutamine and HEPES (HiMedia, India), without antibiotics (complete medium), and kept on ice. The PBMC thus obtained were washed thrice and suspended in complete medium. 2. Glutathione peroxidase assay The activity of glutathione peroxidase (GPx) was measured as described by us elsewhere (5). Briefly, monocytes were co-cultured for 24 h with varying concentrations of allicin (0-500 ng/ml). Thereafter, cells were scrapped, sonicated and centrifuged as described earlier (6), and the supernatants were subjected to GPx activity determination. The GPx activity was quantified in 100

Tags: bone, pbmc, activity, postmenopausal, cell

Beasiswa at Faculty of Pharmacy, University of Iceland

Posted on June 09, 2008 in Pharmacy

.fullpost{display:inline;} Batas Waktu Beasiswa :01-Sep-07 Lokasi Beasiswa :Iceland Detail Beasiswa :PhD Student Fellowship midway Cyclodextrin Scrutiny Structure furthermore physicochemical things of water, as case their dipole occasion, springs from midway form of lot of water molecules bound together up hydrogen bounding. Cavalry of water clusters has been investigated amidst vitro Also there are some indications that soldiery of water clusters can touch aqueous solubility of drugs, singularly lipophilic drugs this encircle only secondary solubility in water. And, there are some indications this water clusters can recovery physical stability of molecular aggregates plus this division of relating aggregates interferes with big league throughput screening since new chemical entities. Conjointly, between vitro studies incorporate indicated that layers of stagnant water molecules could be water clusters. Carbohydrates likewise glycoproteins at membrane surfaces can perhaps enhance cast of related clusters. Little or no index is desirable onward articulation of water clusters between vivo. The conclusion of this feel is to investigate the act on of assemblage division within reach the aqueous solubility of drugs moreover their virtue to permeate biological membranes. Applicants must hold ended MS measure(or smooth) at intervals pharmacy, chemistry, biochemistry, physicalchemistry or at intervals equaling subjects. That is a three year fellowship, everywhere 35,000- EUR per quarter. Seeing bestow finish forth the dynamism of Pharmacy likewise the rein order please visit to the web-site: Net.hi.is/~thorstlo Contact Living soul: Thorsteinn Loftsson Tel: +354 525 4464 Fax: +354 525 4071 E-Mail: thorstlo@hi.is -- Subscribe to Whole story Beasiswa by Email viagra buy cilais generic cialis cheap viagra

Tags: water, clusters, beasiswa, solubility, pharmacy

Protect the nest

Posted on May 21, 2008 in Causes of erectile dysfunction

An Amazing Hoop Why is slow-mo so cool? buy cheap cialis Generic Viagra Cheap Viagra .us'>cheap viagra

Tags: cheap, viagra, buy, generic, cool

RNA interference subject of 2006 Nobel Prize in Medicine

Posted on April 20, 2008 in Diabetes erectile dysfunction

Of the citation to Andrew Z. Fire and Craig C. Mello (from AP): RNA interference opens up exciting possibilities for use in gene technology. Double-stranded RNA molecules have been designed to activate the silencing of specific genes in humans, animals or plants. Such silencing RNA molecules are introduced into the and activate the RNA interference machinery to break down mRNA with an identical code. This method has already become an important research tool in biology and biomedicine. In the future, it is hoped that it will be used in many disciplines including clinical medicine and agriculture. Several recent publications show successful gene silencing in human cells and experimental animals. For instance, a gene causing high blood cholesterol levels was recently shown to be silenced by treating animals with silencing RNA. (...) This year's Nobel Laureates have discovered a fundamental mechanism for controlling the flow of genetic information. Our genome operates by sending instructions for the manufacture of proteins from DNA in the nucleus of the cell to the protein synthesizing machinery in the cytoplasm. These instructions are conveyed by messenger RNA (mRNA). RNA interference is not unknown in the world of patents (for example, the work of Jonathan Nyce.) Meanwhile, in the world of embryonic stem cell research (from Dr. Jerry Yang (Connecticut) and Dr. Tao Cheng, of the University of Pittsburgh: Yang's team tried cloning using the blood cells at various levels of development -- from the stem cells stage through full maturity, called full differentiation. "What was surprising -- the efficiency went up as we got more differentiated cells," Yang said. "That was very, very surprising, very shocking to us." Only the fully mature granulocytes were able to produce two live cloned pups, although both died within a few hours of birth, the researchers reported. "Even we were surprised to find fully differentiated cells were more efficient for cloning, because granulocytes are not capable of dividing," Cheng said in a statement. "In fact, we repeated our experiments six times just to be sure. Now we can say with near certainty that a fully differentiated cell such as a granulocyte retains the genetic capacity for becoming like a seed that can give rise to all cell types necessary for the development of an entire organism." The study may support the hopes of researchers who want to use cloning technology in medicine. Supporters of so-called therapeutic cloning want to some day be able to take a single cell from a patient, perhaps a skin cell, and use it to generate tailor-made tissue or organ transplants. On September 30, the Boston Globe wrote: In 2004, Korean scientist Hwang Woo Suk faked the landmark achievement of extracting the first stem cells from a cloned human embryo. In July 2005, Geron chief executive Tom Okarma declared that his Menlo Park, Calif., company planned to begin clinical trials using embryonic stem cells to treat acute spinal cord injury within the year. Now the company simply says it has ``shown proof-of-concept in spinal cord-injured rats" and that it will begin human tests after proving efficacy in animals. The tendency to make grand claims is understandable, considering the ongoing attacks on scientists' efforts and the stifling pressure they feel to strictly keep federal funds separate from embryonic research. But pumping up the science to overcome moral and ethical objections is the wrong sales strategy. Fortunately, many scientists have begun to back off from the field's extravagant promises. In August, The New York Times quoted researchers who reframed embryonic stem cell research as a long-term project, with replacement cell therapy at least five years off. Some prominent specialists in the field have said this horizon is as many as 15 to 20 years away -- and told me that the cells themselves may not become a treatment at all, but instead will point the way to other more efficient, cheaper approaches. [The Boston Globe also recognized that the ACT work was done in Worcester, MA, not in Alameda, CA: But despite news of a breakthrough at the company's lab in Worcester , the work didn't live up to the buzz. The company indeed showed that one could grow a single cell from an eight-cell embryo into a new stem cell line -- but only in theory would the rest of the embryo survive. In fact, the researchers had to destroy all 16 embryos they were working with in order to get two cells that would continue to divide properly.] *** Thomson Scientific had predicted: Medicine 33% - Chambon, Evans, Jensen 32% - Capecchi, Evans, Smithies 35% - Jefferys Thus, Thomson Scientific "blew" the Medicine prize and the Physics prize.

Tags: cell, rna, stem, medicine, silencing

Molecules Developed by Biotech Companies per Therapeutic Class and Clinical Phase

Posted on April 15, 2008 in Generic medical release

That Database Bill is a one-page prospectus of hard-to-find numerical docket. The Database Catalog is derived from a property commercial including is meant to heedlessly stock a high-level overview of single documents desires. The Database Enumeration is NOT a disclose or a comprehensive check. Additionnal interest regarding this move : Molecules Presented up Biotech Companies per Therapeutic Description moreover Clinical Phase cheap cialis generic online Generic Viagra cheap viagra

Tags:

Sponsors

Search